HPV Infection Clinical Trials in Mianyang, Sichuan
3 recruitingMianyang, Sichuan, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years
HPV-Related CarcinomaHPV Infection
National Vaccine and Serum Institute, China13,500 enrolled8 locationsNCT05262010
Recruiting
Phase 3
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
Vaginal CancerCIN1CIN2+4 more
Shanghai Bovax Biotechnology Co., Ltd.1,348 enrolled1 locationNCT05027776
Recruiting
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Vaginal CancerCIN1CIN2+4 more
Shanghai Bovax Biotechnology Co., Ltd.600 enrolled2 locationsNCT05371353